AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

Search

Oxford Biomedica PLC

Cerrado

334 -0.6

Resumen

Variación precio

24h

Actual

Mínimo

332

Máximo

342.5

Métricas clave

By Trading Economics

Ingresos

22M

-11M

Ventas

27M

78M

Margen de beneficios

-13.726

Empleados

850

EBITDA

25M

5M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+87.57% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

40M

348M

Apertura anterior

334.6

Cierre anterior

334

Oxford Biomedica PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 jun 2025, 20:45 UTC

Ganancias

Broadcom 2Q Sales Climb on Booming AI Demand

5 jun 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 jun 2025, 23:44 UTC

Charlas de Mercado

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 jun 2025, 23:30 UTC

Charlas de Mercado

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 jun 2025, 21:32 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 20:45 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:24 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Rev $15B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Net $4.97B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Adj EPS $1.58 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom Sees 3Q Rev $15.8B >AVGO

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 jun 2025, 19:22 UTC

Charlas de Mercado

Oil Futures Resume Upward Moves -- Market Talk

5 jun 2025, 19:00 UTC

Charlas de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 jun 2025, 18:32 UTC

Charlas de Mercado

Gold Slips After Trump-Xi Call -- Market Talk

5 jun 2025, 18:26 UTC

Ganancias

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 jun 2025, 18:06 UTC

Charlas de Mercado

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 jun 2025, 16:30 UTC

Adquisiciones, fusiones, absorciones

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 jun 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 16:18 UTC

Charlas de Mercado

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 jun 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 jun 2025, 16:03 UTC

Charlas de Mercado

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 jun 2025, 15:49 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Oxford Biomedica PLC previsión

Precio Objetivo

By TipRanks

87.57% repunte

Estimación a 12 Meses

Media 649.002 GBX  87.57%

Máximo 798.369 GBX

Mínimo 498.981 GBX

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Oxford Biomedica PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.